{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T04:33:15Z","timestamp":1783225995672,"version":"3.54.6"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["PRCPJT-Nov22\/100017"],"award-info":[{"award-number":["PRCPJT-Nov22\/100017"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The role of the gut microbiota in carcinogenesis is increasingly being acknowledged. Recent studies in multiple breast cancer mouse models have found that antibiotics, by altering the gut microbiota, can accelerate tumour growth. In humans, a recent cohort study restricted to triple negative breast cancer showed that breast cancer patients using a greater number of antibiotics had markedly worse survival. These studies have raised concerns about repeated antibiotic use in breast cancer patients. In this Registered Report, we investigated whether breast cancer patients using oral antibiotics had increased breast cancer-specific mortality. In population-based cohorts (n\u2009=\u200944,452), we did not observe a statistically significant association between antibiotic prescriptions after diagnosis and breast cancer-specific mortality (adjusted HR\u2009=\u20091.07 95% CI 0.87, 1.33) apart from prescriptions of 12 or more antibiotics (adjusted HR\u2009=\u20091.62 95% CI 1.31, 2.01). This association was weaker after adjustment for infections (adjusted HR\u2009=\u20091.44 95% 1.14, 1.81), when restricted to antibiotics within five years (adjusted HR\u2009=\u20091.33 95% 0.95, 1.84), and was similar for deaths from other causes (adjusted HR\u2009=\u20091.69 95% 1.19, 2.41). Frequent antibiotic users had higher cancer-specific mortality but the attenuation of associations in sensitivity analyses, and similar findings for other causes of death, suggest this increase may reflect residual confounding.\n                    <jats:bold>Protocol registration:<\/jats:bold>\n                    The Stage 1 protocol for this Registered Report was accepted in principle on 7 November 2023. The protocol, as accepted by the journal, can be found at\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"10.6084\/m9.figshare.24746721.v1\" ext-link-type=\"doi\">https:\/\/doi.org\/10.6084\/m9.figshare.24746721.v1<\/jats:ext-link>\n                    .\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-67800-7","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T04:02:25Z","timestamp":1766289745000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antibiotic use and survival from breast cancer: A population-based cohort study in England and Wales"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2689-4335","authenticated-orcid":false,"given":"Chris R.","family":"Cardwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5762-0396","authenticated-orcid":false,"given":"Sarah M.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2882-2079","authenticated-orcid":false,"given":"Andrew JHL","family":"Snelling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9849-4966","authenticated-orcid":false,"given":"Daniel Tzu-Hsuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma C.","family":"Atakpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00dana","family":"McMenamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4123-9611","authenticated-orcid":false,"given":"Stuart A.","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bl\u00e1naid","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol AC","family":"Coupland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron J.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finian J.","family":"Bannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hippisley-Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,21]]},"reference":[{"key":"67800_CR1","doi-asserted-by":"publisher","first-page":"e038767","DOI":"10.1136\/bmjopen-2020-038767","volume":"10","author":"MC Gulliford","year":"2020","unstructured":"Gulliford, M. C., Sun, X., Anjuman, T., Yelland, E. & Murray-Thomas, T. Comparison of antibiotic prescribing records in two UK primary care electronic health record systems: cohort study using CPRD GOLD and CPRD Aurum databases. BMJ Open 10, e038767 (2020).","journal-title":"BMJ Open"},{"key":"67800_CR2","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0140-6736(13)60604-2","volume":"381","author":"SC Davies","year":"2013","unstructured":"Davies, S. C., Fowler, T., Watson, J., Livermore, D. M. & Walker, D. Annual Report of the Chief Medical Officer: infection and the rise of antimicrobial resistance. Lancet 381, 1606\u20131609 (2013).","journal-title":"Lancet"},{"key":"67800_CR3","doi-asserted-by":"publisher","first-page":"e023989","DOI":"10.1136\/bmjopen-2018-023989","volume":"9","author":"X Sun","year":"2019","unstructured":"Sun, X. & Gulliford, M. C. Reducing antibiotic prescribing in primary care in England from 2014 to 2017: population-based cohort study. BMJ Open 9, e023989 (2019).","journal-title":"BMJ Open"},{"key":"67800_CR4","doi-asserted-by":"publisher","first-page":"I236","DOI":"10.1136\/bmj.l236","volume":"364","author":"MC Gulliford","year":"2019","unstructured":"Gulliford, M. C. et al. Effectiveness and safety of electronically delivered prescribing feedback and decision support on antibiotic use for respiratory illness in primary care: REDUCE cluster randomised trial. BMJ 364, I236 (2019).","journal-title":"BMJ"},{"key":"67800_CR5","doi-asserted-by":"publisher","first-page":"ii2","DOI":"10.1093\/jac\/dkx504","volume":"73","author":"FCK Dolk","year":"2018","unstructured":"Dolk, F. C. K., Pouwels, K. B., Smith, D. R. M., Robotham, J. V. & Smieszek, T. Antibiotics in primary care in England: which antibiotics are prescribed and for which conditions? J. Antimicrob. Chemother. 73, ii2\u2013ii10 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"67800_CR6","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1177\/0300060518782519","volume":"46","author":"MS McDonagh","year":"2018","unstructured":"McDonagh, M. S. et al. Interventions to reduce inappropriate prescribing of antibiotics for acute respiratory tract infections: summary and update of a systematic review. J. Int. Med. Res. 46, 3337\u20133357 (2018).","journal-title":"J. Int. Med. Res."},{"key":"67800_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0294-z","volume":"8","author":"A Langdon","year":"2016","unstructured":"Langdon, A., Crook, N. & Dantas, G. The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med. 8, 39 (2016).","journal-title":"Genome Med."},{"key":"67800_CR8","doi-asserted-by":"publisher","first-page":"e035677","DOI":"10.1136\/bmjopen-2019-035677","volume":"10","author":"KT Elvers","year":"2020","unstructured":"Elvers, K. T. et al. Antibiotic-induced changes in the human gut microbiota for the most commonly prescribed antibiotics in primary care in the UK: a systematic review. BMJ Open 10, e035677 (2020).","journal-title":"BMJ Open"},{"key":"67800_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/ismej.2007.3","volume":"1","author":"C Jernberg","year":"2007","unstructured":"Jernberg, C., Lofmark, S., Edlund, C. & Jansson, J. K. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 1, 56\u201366 (2007).","journal-title":"ISME J."},{"key":"67800_CR10","first-page":"326","volume":"67","author":"AP Bhatt","year":"2017","unstructured":"Bhatt, A. P., Redinbo, M. R. & Bultman, S. J. The role of the microbiome in cancer development and therapy. CA Cancer J. Clin. 67, 326\u2013344 (2017).","journal-title":"CA Cancer J. Clin."},{"key":"67800_CR11","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez, M. F. et al. Breast cancer and its relationship with the microbiota. Int. J. Environ. Res. Public Health 15, 1747 (2018).","DOI":"10.3390\/ijerph15081747"},{"key":"67800_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0515-3","volume":"6","author":"J Zhu","year":"2018","unstructured":"Zhu, J. et al. Breast cancer in postmenopausal women is associated with an altered gut metagenome. Microbiome 6, 136 (2018).","journal-title":"Microbiome"},{"key":"67800_CR13","doi-asserted-by":"crossref","unstructured":"Goedert, J. J. et al. Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study. J. Natl Cancer Inst. 107, djv147 (2015).","DOI":"10.1093\/jnci\/djv147"},{"key":"67800_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1144021","volume":"13","author":"MS Thu","year":"2023","unstructured":"Thu, M. S., Chotirosniramit, K., Nopsopon, T., Hirankarn, N. & Pongpirul, K. Human gut, breast, and oral microbiome in breast cancer: a systematic review and meta-analysis. Front. Oncol. 13, 1144021 (2023).","journal-title":"Front. Oncol."},{"key":"67800_CR15","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.3390\/nu13082705","volume":"13","author":"C Bobin-Dubigeon","year":"2021","unstructured":"Bobin-Dubigeon, C. et al. Faecal microbiota composition varies between patients with breast cancer and healthy women: a comparative case-control study. Nutrients 13, 2705 (2021).","journal-title":"Nutrients"},{"key":"67800_CR16","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1158\/0008-5472.CAN-18-3464","volume":"79","author":"C Buchta Rosean","year":"2019","unstructured":"Buchta Rosean, C. et al. Preexisting commensal dysbiosis is a host-intrinsic regulator of tissue inflammation and tumor cell dissemination in hormone receptor-positive breast cancer. Cancer Res 79, 3662\u20133675 (2019).","journal-title":"Cancer Res"},{"key":"67800_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103012","volume":"24","author":"AM McKee","year":"2021","unstructured":"McKee, A. M. et al. Antibiotic-induced disturbances of the gut microbiota result in accelerated breast tumor growth. iScience 24, 103012 (2021).","journal-title":"iScience"},{"key":"67800_CR18","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.jacbts.2019.10.008","volume":"4","author":"GA Van Norman","year":"2019","unstructured":"Van Norman, G. A. Limitations of animal studies for predicting toxicity in clinical trials: is it time to rethink our current approach? JACC Basic Transl. Sci. 4, 845\u2013854 (2019).","journal-title":"JACC Basic Transl. Sci."},{"key":"67800_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105072","volume":"160","author":"J Simin","year":"2020","unstructured":"Simin, J., Tamimi, R. M., Engstrand, L., Callens, S. & Brusselaers, N. Antibiotic use and the risk of breast cancer: a systematic review and dose\u2013response meta-analysis. Pharm. Res. 160, 105072 (2020).","journal-title":"Pharm. Res."},{"key":"67800_CR20","first-page":"307","volume":"17","author":"CM Velicer","year":"2006","unstructured":"Velicer, C. M., Heckbert, S. R., Rutter, C., Lampe, J. W. & Malone, K. Association between antibiotic use prior to breast cancer diagnosis and breast tumour characteristics (United States). Cancer Causes Control 17, 307\u2013313 (2006).","journal-title":"Cancer Causes Control"},{"key":"67800_CR21","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1158\/1055-9965.EPI-13-0454","volume":"22","author":"HS Wirtz","year":"2013","unstructured":"Wirtz, H. S. et al. Frequent antibiotic use and second breast cancer events. Cancer Epidemiol. Biomark. Prev. 22, 1588\u20131599 (2013).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"67800_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93428-w","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Antibiotics modulate neoadjuvant therapy efficiency in patients with breast cancer: a pilot analysis. Sci. Rep. 11, 14024 (2021).","journal-title":"Sci. Rep."},{"key":"67800_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37636-0","volume":"14","author":"KJDA Ransohoff","year":"2023","unstructured":"Ransohoff, K. J. D. A. et al. Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer. Nat. Commun. 14, 2053 (2023).","journal-title":"Nat. Commun."},{"key":"67800_CR24","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/bjc.2012.366","volume":"107","author":"J Maddams","year":"2012","unstructured":"Maddams, J., Utley, M. & Moller, H. Projections of cancer prevalence in the United Kingdom, 2010\u20132040. Br. J. Cancer 107, 1195\u20131202 (2012).","journal-title":"Br. J. Cancer"},{"key":"67800_CR25","doi-asserted-by":"publisher","first-page":"8434","DOI":"10.3390\/curroncol30090614","volume":"30","author":"E Domzaridou","year":"2023","unstructured":"Domzaridou, E. et al. The impact of oral antibiotics prior to cancer diagnosis on overall patient survival: findings from an English population-based cohort study. Curr. Oncol. 30, 8434\u20138443 (2023).","journal-title":"Curr. Oncol."},{"key":"67800_CR26","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.jinf.2016.04.003","volume":"72","author":"JS Brand","year":"2016","unstructured":"Brand, J. S. et al. Infection-related hospitalizations in breast cancer patients: risk and impact on prognosis. J. Infect. 72, 650\u2013658 (2016).","journal-title":"J. Infect."},{"key":"67800_CR27","doi-asserted-by":"publisher","unstructured":"Chia, S. B. et al. Respiratory viral infections awaken metastatic breast cancer cells in lungs. Nature https:\/\/doi.org\/10.1038\/s41586-025-09332-0 (2025).","DOI":"10.1038\/s41586-025-09332-0"},{"key":"67800_CR28","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1093\/jnci\/djt211","volume":"105","author":"J Chubak","year":"2013","unstructured":"Chubak, J., Boudreau, D. M., Wirtz, H. S., McKnight, B. & Weiss, N. S. Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival. J. Natl. Cancer Inst. 105, 1456\u20131462 (2013).","journal-title":"J. Natl. Cancer Inst."},{"key":"67800_CR29","doi-asserted-by":"crossref","unstructured":"Kubecek, O., Paterova, P. & Novosadova, M. Risk factors for infections, antibiotic therapy, and its impact on cancer therapy outcomes for patients with solid tumors. Life (Basel) 11, (2021).","DOI":"10.3390\/life11121387"},{"key":"67800_CR30","doi-asserted-by":"publisher","first-page":"e59762","DOI":"10.2196\/59762","volume":"10","author":"Y Yang","year":"2024","unstructured":"Yang, Y. et al. Assessing the impact of frailty on infection risk in older adults: prospective observational cohort study. JMIR Public Health Surveill. 10, e59762 (2024).","journal-title":"JMIR Public Health Surveill."},{"key":"67800_CR31","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1161\/CIRCRESAHA.119.315279","volume":"126","author":"Y Heianza","year":"2020","unstructured":"Heianza, Y. et al. Duration and life-stage of antibiotic use and risks of all-cause and cause-specific mortality: prospective cohort study. Circ. Res. 126, 364\u2013373 (2020).","journal-title":"Circ. Res."},{"key":"67800_CR32","doi-asserted-by":"publisher","first-page":"e429","DOI":"10.3399\/bjgp13X669149","volume":"63","author":"CA McNulty","year":"2013","unstructured":"McNulty, C. A., Nichols, T., French, D. P., Joshi, P. & Butler, C. C. Expectations for consultations and antibiotics for respiratory tract infection in primary care: the RTI clinical iceberg. Br. J. Gen. Pract. 63, e429\u2013e436 (2013).","journal-title":"Br. J. Gen. Pract."},{"key":"67800_CR33","doi-asserted-by":"publisher","first-page":"e429","DOI":"10.3399\/bjgp12X649124","volume":"62","author":"NA Francis","year":"2012","unstructured":"Francis, N. A. et al. GRACE Project Group. Antibiotics for acute cough: an international observational study of patient adherence in primary care. Br. J. Gen. Pract. 62, e429\u2013e437 (2012).","journal-title":"Br. J. Gen. Pract."},{"key":"67800_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-9-157","volume":"9","author":"DV Ford","year":"2009","unstructured":"Ford, D. V. et al. The SAIL Databank: building a national architecture for e-health research and evaluation. BMC Health Serv. Res 9, 157 (2009).","journal-title":"BMC Health Serv. Res"},{"key":"67800_CR35","doi-asserted-by":"publisher","first-page":"m3873","DOI":"10.1136\/bmj.m3873","volume":"371","author":"Y Vinogradova","year":"2020","unstructured":"Vinogradova, Y., Coupland, C. & Hippisley-Cox, J. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases. BMJ 371, m3873 (2020).","journal-title":"BMJ"},{"key":"67800_CR36","unstructured":"Joint Formulary Committee. British National Formulary, 75th edn (BMJ Group and Pharmaceutical Press, 2018)."},{"key":"67800_CR37","doi-asserted-by":"publisher","first-page":"e0161654","DOI":"10.1371\/journal.pone.0161654","volume":"11","author":"TD Clausen","year":"2016","unstructured":"Clausen, T. D. et al. Broad-spectrum antibiotic treatment and subsequent childhood type 1 diabetes: a nationwide Danish cohort study. PLoS ONE 11, e0161654 (2016).","journal-title":"PLoS ONE"},{"key":"67800_CR38","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/oncolo\/oyad186","volume":"29","author":"A Baker","year":"2024","unstructured":"Baker, A. & Kartsonaki, C. Aspirin use and survival among patients with breast cancer: a systematic review and meta-analysis. Oncologist 29, e1\u2013e14 (2024).","journal-title":"Oncologist"},{"key":"67800_CR39","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/ijc.30185","volume":"139","author":"S Manthravadi","year":"2016","unstructured":"Manthravadi, S., Shrestha, A. & Madhusudhana, S. Impact of statin use on cancer recurrence and mortality in breast cancer: a systematic review and meta-analysis. Int. J. Cancer 139, 1281\u20131288 (2016).","journal-title":"Int. J. Cancer"},{"key":"67800_CR40","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1634\/theoncologist.2015-0096","volume":"20","author":"H Xu","year":"2015","unstructured":"Xu, H. et al. Metformin use is associated with better survival of breast cancer patients with diabetes: a meta-analysis. Oncologist 20, 1236\u20131244 (2015).","journal-title":"Oncologist"},{"key":"67800_CR41","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s12282-017-0789-5","volume":"24","author":"X Yu","year":"2017","unstructured":"Yu, X. et al. Hormone replacement therapy and breast cancer survival: a systematic review and meta-analysis of observational studies. Breast Cancer 24, 643\u2013657 (2017).","journal-title":"Breast Cancer"},{"key":"67800_CR42","doi-asserted-by":"crossref","unstructured":"Tran, N. K., Lash, T. L. & Goldstein, N. D. Practical data considerations for the modern epidemiology student. Glob. Epidemiol. 3, 100066 (2021).","DOI":"10.1016\/j.gloepi.2021.100066"},{"key":"67800_CR43","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White, I. R., Royston, P. & Wood, A. M. Multiple imputation using chained equations: issues and guidance for practice. Stat. Med. 30, 377\u2013399 (2011).","journal-title":"Stat. Med."},{"key":"67800_CR44","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1002\/sim.3618","volume":"28","author":"IR White","year":"2009","unstructured":"White, I. R. & Royston, P. Imputing missing covariate values for the Cox model. Stat. Med. 28, 1982\u20131998 (2009).","journal-title":"Stat. Med."},{"key":"67800_CR45","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1001\/jamaoncol.2023.4508","volume":"10","author":"L McVicker","year":"2024","unstructured":"McVicker, L. et al. Vaginal estrogen therapy use and survival in women with breast cancer: analysis of population-based cohorts from Scotland and Wales. JAMA Oncol. 10, 103\u2013108 (2024).","journal-title":"JAMA Oncol."},{"key":"67800_CR46","doi-asserted-by":"publisher","first-page":"b5087","DOI":"10.1136\/bmj.b5087","volume":"340","author":"LE L\u00e9vesque","year":"2010","unstructured":"L\u00e9vesque, L. E., Hanley, J. A., Kezouh, A. & Suissa, S. Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ 340, b5087 (2010).","journal-title":"BMJ"},{"key":"67800_CR47","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1002\/sim.852","volume":"20","author":"TA Stukel","year":"2001","unstructured":"Stukel, T. A., Demidenko, E., Dykes, J. & Karagas, M. R. Two-stage methods for the analysis of pooled data. Stat. Med. 20, 2115\u20132130 (2001).","journal-title":"Stat. Med."},{"key":"67800_CR48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1039\/C7MD00528H","volume":"9","author":"RJ Melander","year":"2018","unstructured":"Melander, R. J., Zurawski, D. V. & Melander, C. Narrow-spectrum antibacterial agents. MedChemComm 9, 12\u201321 (2018).","journal-title":"MedChemComm"},{"key":"67800_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ctrv.2016.03.011","volume":"46","author":"MV Dieci","year":"2016","unstructured":"Dieci, M. V., Griguolo, G., Miglietta, F. & Guarneri, V. The immune system and hormone-receptor positive breast cancer: is it really a dead end? Cancer Treat. Rev. 46, 9\u201319 (2016).","journal-title":"Cancer Treat. Rev."},{"key":"67800_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2296-7-43","volume":"7","author":"L van Dijk","year":"2006","unstructured":"van Dijk, L., Otters, H. B. & Schuit, A. J. Moderately overweight and obese patients in general practice: a population based survey. BMC Fam. Pract. 7, 43 (2006).","journal-title":"BMC Fam. Pract."},{"key":"67800_CR51","doi-asserted-by":"publisher","first-page":"83134","DOI":"10.18632\/oncotarget.13366","volume":"7","author":"K Wang","year":"2016","unstructured":"Wang, K., Li, F., Zhang, X., Li, Z. & Li, H. Smoking increases risks of all-cause and breast cancer specific mortality in breast cancer individuals: a dose\u2013response meta-analysis of prospective cohort studies involving 39725 breast cancer cases. Oncotarget 7, 83134\u201383147 (2016).","journal-title":"Oncotarget"},{"key":"67800_CR52","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10654-023-00979-5","volume":"38","author":"C Bonet","year":"2023","unstructured":"Bonet, C. et al. The association between body fatness and mortality among breast cancer survivors: results from a prospective cohort study. Eur. J. Epidemiol. 38, 545\u2013557 (2023).","journal-title":"Eur. J. Epidemiol."},{"key":"67800_CR53","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/pds.4368","volume":"27","author":"ME Saine","year":"2018","unstructured":"Saine, M. E. et al. Validity of diagnostic codes to identify hospitalizations for infections among patients treated with oral anti-diabetic drugs. Pharmacoepidemiol. Drug Saf. 27, 1147\u20131150 (2018).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"67800_CR54","doi-asserted-by":"publisher","first-page":"e026251","DOI":"10.1136\/bmjopen-2018-026251","volume":"9","author":"H Hashimoto","year":"2019","unstructured":"Hashimoto, H. et al. Antibiotic prescription among outpatients in a prefecture of Japan, 2012\u20132013: a retrospective claims database study. BMJ Open 9, e026251 (2019).","journal-title":"BMJ Open"},{"key":"67800_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01891-5","volume":"19","author":"RD McDowell","year":"2021","unstructured":"McDowell, R. D., Hughes, C., Murchie, P. & Cardwell, C. A systematic assessment of the association between frequently-prescribed medicines and the risk of common cancers: a series of nested case-control studies. BMC Med. 19, 22 (2021).","journal-title":"BMC Med."},{"key":"67800_CR56","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2307\/2531021","volume":"39","author":"DA Schoenfeld","year":"1983","unstructured":"Schoenfeld, D. A. Sample-size formula for the proportional-hazards regression model. Biometrics 39, 499\u2013503 (1983).","journal-title":"Biometrics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67800-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67800-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67800-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T13:02:00Z","timestamp":1766408520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67800-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,21]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["67800"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67800-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,21]]},"assertion":[{"value":"5 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.A.Mc.I. reports institutional funding for honoraria from Roche, MSD and AstraZeneca, for advisory boards from Roche, Lily and MSD, for talks from Roche and MSD, and research funding from Novartis. S.A.Mc.I. also reports personal funding for talks from B.D. Bard and conference travel and support from Roche and Lilly. A.J.B. reports institutional funding from Pfizer, MSD and Shionogi to support delivery of educational events. The remaining authors declare they have no relevant financial or non-financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11336"}}